Literature DB >> 19875288

Coinheritance of Noonan syndrome and Becker muscular dystrophy.

Argirios Dinopoulos1, Anna Papadopoulou, Panagiota Manta, Kiki Kekou, Tassos Kanelopoulos, Andreas Fretzayas, Sofia Kitsiou.   

Abstract

We describe for the first time a case of a 9-year old boy with co-existence of dystrophinopathy and Noonan syndrome (NS). Although the patient has a severe muscular clinical phenotype, consistent with Duchenne muscular dystrophy (DMD), the diagnosis of Becker muscular dystrophy (BMD) was proposed based on family history (brother with BMD) and confirmed by muscle immunohistochemistry, and molecular study shown an in-frame DMD gene mutation. The patient also fulfilled the clinical criteria of NS and he harbors a hotspot mutation on PTPN11 gene. This genetic combination may be an explanation for the variability of clinical expression in the family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875288     DOI: 10.1016/j.nmd.2009.08.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Tatiana M Fontelonga; Brennan Jordan; Andreia M Nunes; Pamela Barraza-Flores; Nicholas Bolden; Ryan D Wuebbles; Lesley Mathews Griner; Xin Hu; Marc Ferrer; Juan Marugan; Noel Southall; Dean J Burkin
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

2.  Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.

Authors:  Anna Papadopoulou; Michalis Issakidis; Evangelia Gole; Konstantina Kosma; Helen Fryssira; Andreas Fretzayas; Polyxeni Nicolaidou; Sophia Kitsiou-Tzeli
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

Review 3.  Becker muscular dystrophy: case report, review of the literature, and analysis of differentially expressed hub genes.

Authors:  Min Li; Yongli Han; Shuying Wang; Yajie Yu; Mengling Liu; Yingfeng Xia; Ze'an Weng; Ling Zhou; Xiaoyan He; Jun Wang; Zhi He; Liang Yu; Yunhong Zha
Journal:  Neurol Sci       Date:  2021-11-03       Impact factor: 3.307

4.  Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice.

Authors:  Dejia Li; Yongping Yue; Dongsheng Duan
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

Review 5.  A case report with the peculiar concomitance of 2 different genetic syndromes.

Authors:  Alberto Lerario; Irene Colombo; Donatella Milani; Lorenzo Peverelli; Luisa Villa; Roberto Del Bo; Monica Sciacco; Giacomo Pietro Comi; Susanna Esposito; Maurizio Moggio
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.